These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 102231)

  • 1. Meningococcal polysaccharide vaccines: recommendation of the Public Health Service Advisory Committee on Immunization Practices.
    Ann Intern Med; 1978 Dec; 89(6):949-50. PubMed ID: 102231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meningococcal polysaccharide vaccines. Recommendation of the Public Health Service Advisory Committee on Immunization Practices, Center for Disease Control, United States Department of Health, Education, and Welfare, Atlanta, Georgia.
    Ann Intern Med; 1976 Feb; 84(2):179-80. PubMed ID: 814850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meningococcal polysaccharide vaccines: recommendations of the Public Health Service Advisory Committee on Immunization Practices.
    Clin Pediatr (Phila); 1977 Sep; 16(9):764-5. PubMed ID: 408072
    [No Abstract]   [Full Text] [Related]  

  • 4. Meningococcal polysaccharide vaccines. Recommendation of the Public Health Service Advisory Committee on Immunization Practices.
    Conn Med; 1976 Jan; 40(1):57. PubMed ID: 812633
    [No Abstract]   [Full Text] [Related]  

  • 5. Meningococcal disease: a review on available vaccines and vaccines in development.
    Bröker M; Fantoni S
    Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meningococcal disease--New England, 1993-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(29):629-33. PubMed ID: 10458536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Meningococcal disease].
    Dittmann S
    Dtsch Med Wochenschr; 2004 Dec; 129(49):2666-71. PubMed ID: 15578323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serogroup B meningococcal vaccines.
    Zimmer SM; Stephens DS
    Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased case-fatality rate associated with outbreaks of Neisseria meningitidis infection, compared with sporadic meningococcal disease, in the United States, 1994-2002.
    Brooks R; Woods CW; Benjamin DK; Rosenstein NE
    Clin Infect Dis; 2006 Jul; 43(1):49-54. PubMed ID: 16758417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
    Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
    Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Feb; 46(RR-5):1-10. PubMed ID: 9048846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serogroup Y meningococcal disease--Illinois, Connecticut, and selected areas, United States, 1989-1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Nov; 45(46):1010-3. PubMed ID: 8965799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for revaccination of persons at prolonged increased risk for meningococcal disease.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(37):1042-3. PubMed ID: 19779400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opportunities for control of meningococcal disease in the United States.
    Raghunathan PL; Bernhardt SA; Rosenstein NE
    Annu Rev Med; 2004; 55():333-53. PubMed ID: 14746525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal polysaccharide vaccines.
    Gold R
    Hosp Pharm; 1977 Apr; 12(4):201. PubMed ID: 10305440
    [No Abstract]   [Full Text] [Related]  

  • 18. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001.
    Tsang RS; Squires SG; Tam TW
    Can J Microbiol; 2003 Oct; 49(10):633-8. PubMed ID: 14663497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of meningococcal disease.
    Kimmel SR
    Am Fam Physician; 2005 Nov; 72(10):2049-56. PubMed ID: 16342836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of meningococcal group A and C polysaccharide vaccine on nasopharyngeal carrier state.
    Stroffolini T; Angelini L; Galanti I; Occhionero M; Congiu ME; Mastrantonio P
    Microbiologica; 1990 Jul; 13(3):225-9. PubMed ID: 2125684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.